Robert Rouse, Head of US Market Access, CSL Behring
Advertisement
Articles by Robert Rouse, Head of US Market Access, CSL Behring
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Prior authorization isn’t shrinking. Its savings are
2
Novo Nordisk launches Awiqli, a once-weekly basal insulin
3
David Chen, Pharm.D., on Kaiser Permanente's biosimilar strategy
4
Once-weekly pemvidutide begins phase 3 trial for MASH
5